Current stage -Stage III Posts on Medivizor
Navigation Menu

Current stage -Stage III Posts on Medivizor

Apalutamide does not affect health-related quality of life in patients with localized prostate cancer

Posted by on Nov 28, 2018 in Prostate cancer | 0 comments

In a nutshell This study investigated the effect of apalutamide (Erleada) on health-related quality of life (H-QoL) in patients with prostate cancer. This study found that apalutimide preserved H-QoL while prolonging time taken for cancer to spread.  Some background One treatment option for patients with prostate cancer is androgen...

Read More

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Posted by on Nov 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study compared two different types of radiation therapy after prostate surgery for prostate cancer, hypofractionated postprostatectomy radiation therapy (hypoPORT) and conventional postprostatectomy radiation therapy (coPORT). Results showed that hypoPORT may be effective in prostate cancer control and with similar side effects as...

Read More

Guidelines for hypofractionated radiation therapy for localized prostate cancer

Posted by on Nov 10, 2018 in Prostate cancer | 0 comments

In a nutshell This study reviewed the current recommendations for treatment doses of radiation therapy for different stages of prostate cancer.  Some background Hypo-fractionated radiation therapy (HFRT) for early-stage prostate cancer is a safe and effective treatment option. It involves a shorter course of treatment with larger doses...

Read More

Better survival for patients with new metastatic prostate cancer with previous prostate surgery

Posted by on Oct 19, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the effect previous treatment has on overall survival for patients with metastatic (spread) prostate cancer. This study found that patients who had previous prostate surgery and radiation had improved overall survival.  Some background Localized prostate cancer can be treated using prostate-removing...

Read More

2018 recommendations for the treatment of localized prostate cancer: Part II

Posted by on Sep 25, 2018 in Prostate cancer | 0 comments

In a nutshell This article reviewed treatment guidelines that have been recommended for patients with early-stage prostate cancer. Some background This analysis of existing treatment guidelines was done by the leading experts in prostate cancer research. They have made recommendations on the treatment of early-stage prostate cancer.  Methods...

Read More

Comparing daily versus weekly imaging checks in radiation therapy for prostate cancer

Posted by on Aug 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the best timing of treatment verification imaging used in radiation therapy for patients with prostate cancer. This study found that patients undergoing daily imaging had less risk of their cancer returning and had reduced rectal side-effects. Some background One main treatment option for prostate cancer...

Read More

PSA response after cabazitaxel treatment is associated with improved progression-free survival in men with metastatic castration-resistant prostate cancer.

Posted by on Jan 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to examine the links between prostate specific antigen (PSA, a protein present in prostate cancer) and survival in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. This studty concluded that PSA response after cabazitaxel treatment is associated with improved...

Read More

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Posted by on Jan 21, 2017 in Prostate cancer | 1 comment

In a nutshell The aim of this study was to determine whether radiation therapy in combination with hormonal therapy improved survival in men with prostate cancer that has spread to the lymph nodes after surgery. Researchers concluded that patients treated with radiation therapy and hormone therapy had a significantly higher survival rate compared to...

Read More

High-risk prostate cancer: Is there a survival benefit when chemotherapy is administered before surgery?

Posted by on Nov 28, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefit of administering chemotherapy before prostate surgery in men with intermediate- to high-risk prostate cancer. Researchers reported preliminary evidence of a cancer-specific survival benefit when chemotherapy was administered before surgery. Some background Prostate surgery is a first-line treatment for...

Read More